Robert E. Sulentic - 10 Feb 2023 Form 4 Insider Report for CBRE GROUP, INC. (CBRE)

SEC evidence 5 facts
Form type
4
Accepted by SEC
14 Feb 2023, 18:23:13 UTC
Previous filing
14 Dec 2022
Next filing
28 Feb 2023
SEC filing
View on sec.gov
Reporting owner 1 fact
Reporting owner signature
/s/ Cindy Kee, Attorney-in-Fact for Robert E. Sulentic

Key filing fact

Robert E. Sulentic filed Form 4 for CBRE GROUP, INC. (CBRE) on 14 Feb 2023.

Key facts

  • This page summarizes Robert E. Sulentic's Form 4 filing for CBRE GROUP, INC. (CBRE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Feb 2023, 18:23.

Change

  • Previous filing in this sequence was filed on 14 Dec 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

CBRE transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+167,542
Change %
+17%
Price
$0.000000
Shares after
1,162,756
Date
10 Feb 2023
Ownership
Direct
Footnotes
F1
* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id Content
F1 The Issuer granted these securities to the Reporting Person on March 3, 2021 as part of the Reporting Person's 2021 annual equity award. On February 10, 2023, the Compensation Committee of the Board of Directors of the Issuer certified the Issuer's Adjusted EPS performance necessary for this award to vest. As such, these securities will vest in full on March 3, 2024, subject to forfeiture in certain circumstances as set forth in the award agreement for these securities.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .